MAUDE Adverse Event Report: CERAMENT BONE VOID FILLER CERAMENT BONE VOID FILLER

Model Number	A0210-11
Medical Device Problem Codes	Device Dislodged or Dislocated (2923); Migration (4003)
Health Effect - Clinical Codes	Wound Dehiscence (1154); Infiltration into Tissue (1931); Inflammation (1932)
Date of Event	02/29/2024
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Mlot1127 (a0210-11, cerament bone void filler), manufacturing date: 06/29/2023, expiration date: 24/03/2026.Manufacturer batch investigation: review of batch records for mlot1127 including quality release results has been performed.All results from release tests were within limits.The first device from the batch was sold in (b)(6) 2023, (b)(4) devices of the total batch size of (b)(4) devices have been sold.No other similar complaints have been received for the batch.The medical investigation of the complaint will be submitted in a follow-up report after receiving additional data from the responsible physician.
Event or Problem Description
Post-operatively the incision healed nicely then weeks later the incision opened and started draining liquid cerament.On second operation, all of the cerament within the cavity was liquid - not solid.Return to operating room to remove cerament and re-close the incision.Unnecessary anesthesia, cost of re-operation.Significant delay in patient's ability to return to activity.
Additional Manufacturer Narrative
Mlot1127 (a0210-11, cerament bone void filler), manufacturing date: 06/29/2023, expiration date: 24/03/2026 manufacturer batch investigation: review of batch records for mlot1127 including quality release results has been performed.All results from release tests were within limits.The first device from the batch was sold in 08/07/2023, (b)(4) devices of the total batch size of (b)(4) devices have been sold.No other similar complaints have been received for the batch.The medical investigation of the complaint will be submitted in a follow-up report after recieving additional data from the responsible physician.The following information was added 20th june 2024: additional information was received on the 24th april 2024 from the surgeon.The information to this complaint is sufficient to draw several conclusions."white drainage" is a well-known occurrence in calcium-based bone void fillers.The incident considered is an expected and foreseeable effect which was described in the instructions for use and in the risk assessment for cerament bone void filler.The surgeon also informed us that cultures were negative and patient is now healing well.The product was used in a reasonable way.The patient had complications which resulted in a re-operation, and although the incident is considered as expected and foreseeable event which is described in the risk assessment and the instructions for use for cerament bone void filler.It was decided to perform some further investigations at bonesupport, therefore a safety related capa (capa-0166) was initiated.
Event or Problem Description
Post-operatively the incision healed nicely then weeks later the incision opened and started draining liquid cerament.On second operation, all of the cerament within the cavity was liquid - not solid.Return to operating room to remove cerament and re-close the incision.Unnecessary anesthesia, cost of re-operation.Significant delay in patient's ability to return to activity.
Additional Manufacturer Narrative
Mlot1127 (a0210-11, cerament bone void filler), manufacturing date: 06/29/2023, expiration date: 24/03/2026.Manufacturer batch investigation: review of batch records for mlot1127 including quality release results has been performed.All results from release tests were within limits.The first device from the batch was sold in 08/07/2023, 379 devices of the total batch size of 531 devices have been sold.No other similar complaints have been received for the batch.The medical investigation of the complaint will be submitted in a follow-up report after recieving additional data from the responsible physician.The following information was added 20th june 2024: additional information was received on the 24th april 2024 from the surgeon.The information to this complaint is sufficient to draw several conclusions."white drainage" is a well-known occurrence in calcium-based bone void fillers.The incident considered is an expected and foreseeable effect which was described in the instructions for use and in the risk assessment for cerament bone void filler.The surgeon also informed us that cultures were negative and patient is now healing well.The product was used in a reasonable way.The patient had complications which resulted in a re-operation, and although the incident is considered as expected and foreseeable event which is described in the risk assessment and the instructions for use for cerament bone void filler.It was decided to perform some further investigations at bonesupport, therefore a safety related capa (capa-0166) was initiated.The following information was added on the 10th of july 2024: investigations are still ongoing at bonesupport, within capa-0166 as referred above.
Event or Problem Description
Post-operatively the incision healed nicely then weeks later the incision opened and started draining liquid cerament.On second operation, all of the cerament within the cavity was liquid - not solid.Return to operating room to remove cerament and re-close the incision.Unnecessary anesthesia, cost of re-operation.Significant delay in patient's ability to return to activity.
Additional Manufacturer Narrative
The root-cause investigation concluded that there is no clear cause other than being an expected undesirable side effect."white drainage" is a well-known occurrence in calcium-based bone void fillers.The incident considered is an expected and foreseeable effect which is described in the instructions for use (ifu0007-12) and in the risk assessment for cerament bone void filler.

• Brand Name: CERAMENT BONE VOID FILLER
• Common Device Name: CERAMENT BONE VOID FILLER
• Manufacturer (Section D): CERAMENT BONE VOID FILLER; scheelevägen 19; ideon science park; lund, 223 7 0 SW; SW 223 70 SWE
• Manufacturer (Section G): BONESUPPORT AB; scheelevägen 19; ideon science park; lund, 223 7 0 SW; SW 223 70 SWE
• Manufacturer Contact: fareda khalil ; scheelevägen 19; ideon science park; lund, 223 7-0 SW ; SW 223 70 SWE
• MDR Report Key: 19189466
• Report Number: 3005304945-2024-00004
• Device Sequence Number: 8305257
• Product Code: MQV
• UDI-Device Identifier: 07350055430066
• UDI-Public: 07350055430066
• Combination Product (Y/N): N
• Initial Reporter State: CA
• Initial Reporter Country: US
• PMA/510(K) Number: K201535
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2023
• Device Explanted Year: 2024
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Health Professional
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup,Followup,Followup
• Report Date (Section B): 03/29/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Model Number: A0210-11
• Device Catalogue Number: A0210-11
• Device Lot Number: MLOT1127
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 03/29/2024
• Supplement Date Received by Manufacturer: 03/29/2024; 03/29/2024; 03/29/2024
• Initial Report FDA Received Date: 04/26/2024
• Supplement Report FDA Received Date: 06/20/2024; 07/10/2024; 10/15/2024
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 06/29/2023
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Hospitalization; Required Intervention
• Patient Age: 13 YR
• Patient Sex: Female
• Patient Weight: 55 KG